One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Off-clamp Versus On-clamp Partial Nephrectomy: Re-envision of a Dilemma
Riccardo Bertolo a, Alessandro Antonelli a, Andrea Minervini b c, Riccardo Campi c d
doi : 10.1016/j.euo.2023.12.009
Volume 7, Issue 2, April 2024, Pages 173-176
Liquid Biopsies Will Drive Treatment Decisions in the Future
J. Jesus Cendejas-Gomez a, Brant A. Inman a b c
doi : 10.1016/j.euo.2023.10.024
Volume 7, Issue 2, April 2024, Pages 177-178
Combining PARP Inhibitors and Androgen Receptor Signalling Inhibitors in Metastatic Prostate Cancer: A Quantitative Synthesis and Meta-analysis
Carlo Messina a †, Emilio Francesco Giunta b †, Alessio Signori c †, Sara Elena Rebuzzi d e, Giuseppe Luigi Banna f o, Akash Maniam f, Sebastiano Buti g h, Carlo Cattrini i, Giuseppe Fornarini j, Matteo Bauckneht c k, Alastair Greystoke l, Ruth Plummer l, Christoph Oing l m ‡, Pasquale Rescigno l n ‡
doi : 10.1016/j.euo.2023.07.013
Volume 7, Issue 2, April 2024, Pages 179-188
Diagnostic Performance of Prostate-specific Antigen Density for Detecting Clinically Significant Prostate Cancer in the Era of Magnetic Resonance Imaging: A Systematic Review and Meta-analysis
Shu Wang a, Jason Kozarek b, Ryan Russell a, Max Drescher a, Amir Khan a, Vikas Kundra c, Kathryn Hughes Barry d, Michael Naslund a, M. Minhaj Siddiqui a e
doi : 10.1016/j.euo.2023.08.002
Volume 7, Issue 2, April 2024, Pages 189-203
Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Active Surveillance for Prostate Cancer Trial (PASPoRT)
Joris G. Heetman a, Jules Lavalaye b, Pepijn D. Polm a, Timo F.W. Soeterik a, Lieke Wever a, Leonor J. Paulino Pereira a, Erik J.R.J. van der Hoeven c, Harm H.E. van Melick a, Roderick C.N. van den Bergh a
doi : 10.1016/j.euo.2023.05.004
Volume 7, Issue 2, April 2024, Pages 204-210
Significant Survival Differences for Grade Group 4 and Grade Group 5 Prostate Cancer: Detailed Reporting of Pathohistology and Modern Diagnostic Algorithms Are Needed To Tailor Treatment
Axel Heidenreich
doi : 10.1016/j.euo.2023.11.004
Volume 7, Issue 2, April 2024, Pages 211-212
Prognosis of Gleason Score 9–10 Prostatic Adenocarcinoma in Needle Biopsies: A Nationwide Population-based Study
Lars Egevad a, Chiara Micoli b, Hemamali Samaratunga c, Brett Delahunt a d, Hans Garmo e f, Pär Stattin f, Martin Eklund b
doi : 10.1016/j.euo.2023.11.002
Volume 7, Issue 2, April 2024, Pages 213-221
Transcriptomic Heterogeneity of Expansile Cribriform and Other Gleason Pattern 4 Prostate Cancer Subtypes
Meera R. Chappidi a, Martin Sjöström b, Nancy Y. Greenland c, Janet E. Cowan a, Avi S. Baskin a, Kevin Shee a, Jeffry P. Simko c, Emily Chan c, Bradley A. Stohr c, Samuel L. Washington 3rd a d, Hao G. Nguyen a, David A. Quigley a d, Elai Davicioni e, Felix Y. Feng a b, Peter R. Carroll a, Matthew R. Cooperberg a d
doi : 10.1016/j.euo.2023.06.007
Volume 7, Issue 2, April 2024, Pages 222-230
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters
Elio Mazzone a b †, Giorgio Gandaglia a b †, Daniele Robesti a b, Pawel Rajwa c d, Juan Gomez Rivas e, Laura Ibáñez e, Timo F.W. Soeterik f g, Lorenzo Bianchi h, Luca Afferi i, Claudia Kesch j k, Christopher Darr j k, Hongqian Guo l, Junlong Zhuang l, Fabio Zattoni m, Wolfgang P. Fendler k n, Daniele Amparore o, Nicolai A. Huebner c, Alexander Giesen p, Steven Joniau p, Riccardo Schiavina h…Alberto Briganti a b
doi : 10.1016/j.euo.2023.08.010
Volume 7, Issue 2, April 2024, Pages 231-240
Identification of a Predictive Genomic Biomarker for Prostate-directed Therapy in Synchronous Low-volume Metastatic Castration-sensitive Prostate Cancer
Philip Sutera a, Amol C. Shetty b c, Yang Song b c, Theresa Hodges b c, Tung Hoang a d, Zaker Rana c, Kenneth Pienta e f, Felix Feng g, Daniel Y. Song a e f, Theodore DeWeese a e f, Silke Gillessen h, Christopher Sweeney i, Nicholas James j, Gerhardt Attard k, Matthew Deek l, Phuoc T. Tran c
doi : 10.1016/j.euo.2023.07.014
Volume 7, Issue 2, April 2024, Pages 241-247
Identification of Genes with Rare Loss of Function Variants Associated with Aggressive Prostate Cancer and Survival
Edward J. Saunders a †, Tokhir Dadaev a †, Mark N. Brook a, Sarah Wakerell a, Koveela Govindasami a, Reshma Rageevakumar a, Nafisa Hussain a, Andrea Osborne a, Diana Keating a, Artitaya Lophatananon b, Kenneth R. Muir b, UKGPCS Collaborators, Burcu F. Darst c d, David V. Conti c, Christopher A. Haiman c, Antonis C. Antoniou e, Rosalind A. Eeles a f ‡, Zsofia Kote-Jarai a ‡
doi : 10.1016/j.euo.2024.02.003
Volume 7, Issue 2, April 2024, Pages 248-257
A Fully Automated Artificial Intelligence System to Assist Pathologists’ Diagnosis to Predict Histologically High-grade Urothelial Carcinoma from Digitized Urine Cytology Slides Using Deep Learning
Keisuke Tsuji a †, Masatomo Kaneko a †, Yuki Harada a, Atsuko Fujihara a, Kengo Ueno b, Masaya Nakanishi b, Eiichi Konishi c, Tetsuro Takamatsu d, Go Horiguchi e, Satoshi Teramukai e, Toshiko Ito-Ihara f, Osamu Ukimura a
doi : 10.1016/j.euo.2023.11.009
Volume 7, Issue 2, April 2024, Pages 258-265
The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features
E. Jason Abel a, Viraj A. Master b, Philippe E. Spiess c, Jay D. Raman d, Daniel D. Shapiro e, Wade J. Sexton c, Logan Zemp c, Dattatraya Patil b, Kate Lauer a, Glenn O. Allen a, Surena F. Matin e, Jose A. Karam e
doi : 10.1016/j.euo.2023.06.008
Volume 7, Issue 2, April 2024, Pages 266-274
Robot-assisted Simple Enucleation Versus Standard Robot-assisted Partial Nephrectomy for Low- or Intermediate-complexity, Clinical T1 Renal Tumors: A Randomized Controlled Noninferiority Trial
Qun Lu a †, Xiaozhi Zhao a †, Shun Zhang a †, Guoli Wang a, Changwei Ji a, Guangxiang Liu a, Yao Fu b, Linfeng Xu a, Shiwei Zhang a, Xiaogong Li a, Weidong Gan a, Gutian Zhang a, Hongqian Guo a
doi : 10.1016/j.euo.2023.07.019
Volume 7, Issue 2, April 2024, Pages 275-281
Early On-treatment Circulating Tumor DNA Measurements and Response to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer
Sofie H. Tolmeijer a, Sandra van Wilpe a, Maartje J. Geerlings b, Daniel von Rhein b, Tineke J. Smilde c, Iris S.H. Kloots a, Harm Westdorp a, Mustafa Coskuntürk a, Irma M. Oving d, Jolique A. van Ipenburg e, Antoine G. van der Heijden f, Tom Hofste b, Marjan M. Weiss b, Jack A. Schalken f, Winald R. Gerritsen a, Marjolijn J.L. Ligtenberg b e †, Niven Mehra a â€
doi : 10.1016/j.euo.2023.08.009
Volume 7, Issue 2, April 2024, Pages 282-291
Olaparib plus Abiraterone for Metastatic Castration-resistant Prostate Cancer: Pharmacokinetics Data from the PROpel Trial
Andrew J. Armstrong a, Noel Clarke b, Mototsugu Oya c, Giuseppe Procopio d, Juliana de Menezes e, João Daniel Guedes f, Pooja Ghatalia g, Franco Nolè h, Omar Din i, Philipp Spiegelhalder j, Ivan Mincik k, Robbert van Alphen l, Nicolaas Lumen m, Christian Hosius n, Diansong Zhou o, Laura Barker p, Melanie Dujka q, Fred Saad r
doi : 10.1016/j.euo.2023.10.004
Volume 7, Issue 2, April 2024, Pages 292-296
From an On-site Program to a Mobile App for Prehabilitation and Rehabilitation for Robotic Radical Prostatectomy: Lessons Learned from 5 Years of Experience, the COVID-19 Outbreak, and Comparison with Nationwide Data
Guillaume Ploussard, Claudia Kesch, Giorgio Calleris, Bogdan Buhas, Ambroise Salin, Christophe Almeras, Guillaume Loison, Marine Lesourd, Christophe Tollon, Benjamin Pradère, Jean-Baptiste Beauval
doi : 10.1016/j.euo.2023.10.007
Volume 7, Issue 2, April 2024, Pages 297-299
Re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non–muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590–596
Francesco Montorsi, Giuseppe Rosiello, Giorgio Gandaglia
doi : 10.1016/j.euo.2023.09.016
Volume 7, Issue 2, April 2024, Page 300
Reply to Francesco Montorsi, Giuseppe Rosiello, and Giorgio Gandaglia’s Letter to the Editor re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non–muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590–596
Roberto Contieri a b, Patrick J. Hensley c, Ashish M. Kamat a
doi : 10.1016/j.euo.2023.09.018
Volume 7, Issue 2, April 2024, Page 301
Reply to Eduard Roussel, Riccardo Bertolo, Chiara Ciccarese, et al’s Letter to the Editor re: E. Jason Abel, Viraj A. Master, Philippe E. Spiess, et al. The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features. Eur Urol Oncol. 2023;6:266–274
E. Jason Abel a, Viraj A. Master b, Philippe E. Spiess c, Jay D. Raman d, Daniel D. Shapiro e, Wade J. Sexton c, Logan Zemp c, Dattatraya Patil b, Kate Lauer a, Glenn O. Allen a, Surena F. Matin e, Jose A. Karam e
doi : 10.1016/j.euo.2023.10.025
Volume 7, Issue 2, April 2024, Pages 302-303
Re: E. Jason Abel, Viraj A. Master, Philippe E. Spiess, et al. The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features. Eur Urol Oncol. 2023;6:266–274
Eduard Roussel a, Riccardo Bertolo b, Chiara Ciccarese c, Laura Marandino d, Michele Marchioni e, Riccardo Campi f g h †, Maarten Albersen a †, European Association of Urology Young Academic Urologists Renal Cancer Working Group
doi : 10.1016/j.euo.2023.10.027
Volume 7, Issue 2, April 2024, Pages 304-305
Reply to Fumihiko Urabe, Takashi Yoshioka, and Takahiro Kimura’s Letter to the Editor re: Felix Seelemeyer, David Pfister, Robert Pappesch, Sabine Merkelbach-Bruse, Pia Paffenholz and Axel Heidenreich. Evaluation of a miRNA-371a-3p Assay for Predicting Final Histopathology in Patients Undergoing Primary Nerve-sparing Retroperitoneal Lymphadenectomy for Stage IIA/B Seminoma or Nonseminoma. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.10.021
Felix Seelemeyer a, David Pfister a, Robert Pappesch c, Sabine Merkelbach-Bruse c, Pia Paffenholz a, Axel Heidenreich a b
doi : 10.1016/j.euo.2024.01.001
Volume 7, Issue 2, April 2024, Page 306
Re: Felix Seelemeyer, David Pfister, Robert Pappesch, et al. Evaluation of a miRNA-371a-3p Assay for Predicting Final Histopathology in Patients Undergoing Primary Nerve-sparing Retroperitoneal Lymphadenectomy for Stage IIA/B Seminoma or Nonseminoma. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.10.021
Fumihiko Urabe a, Takashi Yoshioka b, Takahiro Kimura a
doi : 10.1016/j.euo.2023.11.025
Volume 7, Issue 2, April 2024, Page 307
Reply to Jorge Abreu-Gomez, Masoom Haider, and Sangeet Ghai’s Letter to the Editor re: Francesco Giganti, Louise Dickinson, Clement Orczyk, et al. Prostate Imaging after Focal Ablation (PI-FAB): A Proposal for a Scoring System for Multiparametric MRI of the Prostate After Focal Therapy. Eur Urol Oncol. 2023;6:629–634
Francesco Giganti a b, Louise Dickinson a, Clare Allen a, Caroline M. Moore b c
doi : 10.1016/j.euo.2023.08.012
Volume 7, Issue 2, April 2024, Page 308
Re: Gopal Sharma, Milap Shah, Puneet Ahluwalia, et al. Off-clamp Versus On-clamp Robot-assisted Partial Nephrectomy: A Propensity-matched Analysis. Eur Urol Oncol. 2023;6:525–530
Riccardo Bertolo a, Pierluigi Bove a, Alessandro Antonelli b, AGILE Italian Group for Advanced Laparo-Endoscopic Surgery
doi : 10.1016/j.euo.2023.08.006
Volume 7, Issue 2, April 2024, Pages 309-310
The Need for Serum Testosterone Measurement with Liquid Chromatography and Tandem Mass Spectrometry in Prostate Cancer Patients Undergoing Castration
Juan Morote, Adriana Aguilar, Enrique Trilla
doi : 10.1016/j.euo.2023.08.008
Volume 7, Issue 2, April 2024, Page 311
